DK1353923T3 - Forbedret fremgangsmåde til syntese af carbapenem - Google Patents

Forbedret fremgangsmåde til syntese af carbapenem

Info

Publication number
DK1353923T3
DK1353923T3 DK02701042T DK02701042T DK1353923T3 DK 1353923 T3 DK1353923 T3 DK 1353923T3 DK 02701042 T DK02701042 T DK 02701042T DK 02701042 T DK02701042 T DK 02701042T DK 1353923 T3 DK1353923 T3 DK 1353923T3
Authority
DK
Denmark
Prior art keywords
carbapenem
synthesis
improved method
improved
Prior art date
Application number
DK02701042T
Other languages
Danish (da)
English (en)
Inventor
John M Williams
Renato Skerlj
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK1353923T3 publication Critical patent/DK1353923T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02701042T 2001-01-16 2002-01-11 Forbedret fremgangsmåde til syntese af carbapenem DK1353923T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26193301P 2001-01-16 2001-01-16
US29344001P 2001-05-24 2001-05-24
PCT/US2002/000821 WO2002057266A1 (fr) 2001-01-16 2002-01-11 Procede ameliore pour la synthese de carbapenems

Publications (1)

Publication Number Publication Date
DK1353923T3 true DK1353923T3 (da) 2005-01-31

Family

ID=26948925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02701042T DK1353923T3 (da) 2001-01-16 2002-01-11 Forbedret fremgangsmåde til syntese af carbapenem

Country Status (29)

Country Link
US (1) US7071330B2 (fr)
EP (1) EP1353923B1 (fr)
JP (1) JP4098626B2 (fr)
KR (1) KR100827562B1 (fr)
CN (1) CN1249065C (fr)
AR (1) AR035728A1 (fr)
AT (1) ATE278691T1 (fr)
AU (1) AU2002234240B2 (fr)
BR (1) BR0206372A (fr)
CA (1) CA2433874C (fr)
CZ (1) CZ301440B6 (fr)
DE (1) DE60201498T2 (fr)
DK (1) DK1353923T3 (fr)
EA (1) EA006098B1 (fr)
EG (1) EG23993A (fr)
ES (1) ES2227423T3 (fr)
HR (1) HRP20030566B1 (fr)
HU (1) HUP0302764A3 (fr)
IL (2) IL156507A0 (fr)
MX (1) MXPA03006322A (fr)
NZ (1) NZ527191A (fr)
PL (1) PL362912A1 (fr)
PT (1) PT1353923E (fr)
RS (1) RS50494B (fr)
SI (1) SI1353923T1 (fr)
SK (1) SK287350B6 (fr)
TW (1) TWI318627B (fr)
UA (1) UA74870C2 (fr)
WO (1) WO2002057266A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
PL218808B1 (pl) * 2001-09-26 2015-01-30 Merck & Co Inc Sposób zmniejszania poziomów rozpuszczalników organicznych w stałym karbapenemie
WO2003026572A2 (fr) * 2001-09-26 2003-04-03 Merck & Co., Inc. Formes cristallines d'antibiotiques a base de carbapeneme et procedes de preparation
PL368984A1 (en) * 2001-11-16 2005-04-04 Ranbaxy Laboratories Limited Process for the preparation of crystalline imipenem
KR101031143B1 (ko) * 2002-11-13 2011-04-27 가부시키가이샤 가네카 경구 투여용 카르바페넴 화합물의 신규 합성 중간체 및그의 제조 방법
DE102005025899A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Aufbereitung eines Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisches
WO2007031858A2 (fr) * 2005-09-15 2007-03-22 Orchid Chemicals And Pharmaceuticals Limited Procede ameliore de preparation d'un antibiotique beta-lactame
JP5373390B2 (ja) * 2006-03-28 2013-12-18 株式会社カネカ カルバペネム化合物の改良された製造方法
US8293894B2 (en) 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101357920B (zh) * 2007-06-22 2011-01-12 山东轩竹医药科技有限公司 含有巯基吡咯烷甲酰胺基三嗪的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
WO2010124531A1 (fr) 2009-04-30 2010-11-04 石药集团中奇制药技术（石家庄）有限公司 Intermédiaires du carbapénème, compositions les contenant et leurs procédés de préparation
CN102918041A (zh) * 2010-05-21 2013-02-06 山东轩竹医药科技有限公司 碳青霉烯衍生物或其水合物的晶型及其制备方法与用途
CN103025733B (zh) * 2010-06-03 2015-11-25 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
WO2012038979A2 (fr) * 2010-09-24 2012-03-29 Sequent Anti Biotics Private Limited Procédé de préparation d'ertapénem
CN102558182B (zh) 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
WO2013121279A2 (fr) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Procédé de préparation d'ertapénem
WO2014097221A1 (fr) * 2012-12-21 2014-06-26 Ranbaxy Laboratories Limited Procédé pour la purification de biapenem
WO2015145161A1 (fr) * 2014-03-27 2015-10-01 Johnson Matthey Public Limited Company Procédé de préparation d'un antibiotique carbapénème

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794554A (fr) * 1972-01-31 1973-07-26 Lilly Co Eli Nouveaux derives de penicilline et de cephalusporine
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US3897424A (en) * 1973-07-23 1975-07-29 Lilly Co Eli Process for 7-{62 -amino-7-{60 -methoxy-cephalosporanic acid esters and related compounds
AR207327A1 (es) * 1974-02-06 1976-09-30 Lilly Co Eli Un procedimiento para preparar acidos 3-cefem 3-sulfonatos y sus esteres
US4001226A (en) * 1974-12-04 1977-01-04 Eli Lilly And Company 3-(substituted)carbonylamino cephem derivatives
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
US3985746A (en) * 1975-03-25 1976-10-12 E. R. Squibb & Sons, Inc. 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates
US4217453A (en) * 1978-07-24 1980-08-12 Merck & Co., Inc. 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
US4656263A (en) * 1979-03-05 1987-04-07 Pfizer Inc. 6-β-substituted penicillanic acid compound free of the 6-α-epimer
US4299954A (en) * 1979-11-05 1981-11-10 Eli Lilly And Company Cephalosporin vinyl halides
US4414155A (en) 1980-01-14 1983-11-08 Merck & Co., Inc. Synthesis of thienamycin via esters of (3SR, 4RS)-3-[(SR)-1-hydroxyethyl]-β,2-dioxo-4-azetidinebutanoic acid
US4269772A (en) 1980-01-14 1981-05-26 Merck & Co., Inc. Synthesis of thienamycin via trans-3-carboxymethylene-4-carboxy-5-methyl-Δ2 -isoxazoline
US4369187A (en) * 1980-02-06 1983-01-18 Merck & Co., Inc. 3-Substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
US4383946A (en) 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
US4501741A (en) * 1983-04-12 1985-02-26 Eli Lilly And Company Cephalosporin antibiotics
US4783453A (en) * 1985-06-10 1988-11-08 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids
JPS6475488A (en) * 1987-09-17 1989-03-22 Sumitomo Pharma Production of beta-lactam compound
US5034384A (en) 1990-08-01 1991-07-23 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem antibacterial agents
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (fr) * 1992-03-26 1993-09-27 Frederic H. Jung Composes antibiotiques
HRP970281B1 (en) 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
UA62920C2 (en) 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6063931A (en) 1997-07-09 2000-05-16 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
US5872250A (en) 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
JP3953274B2 (ja) * 1998-03-02 2007-08-08 メルク エンド カムパニー インコーポレーテッド カルバペネム抗生物質の合成方法

Also Published As

Publication number Publication date
EA200300804A1 (ru) 2003-12-25
DE60201498T2 (de) 2005-11-17
MXPA03006322A (es) 2003-10-06
CN1486318A (zh) 2004-03-31
SI1353923T1 (en) 2005-02-28
EA006098B1 (ru) 2005-08-25
CA2433874A1 (fr) 2002-07-25
CZ301440B6 (cs) 2010-03-03
IL156507A0 (en) 2004-01-04
CZ20031911A3 (cs) 2003-10-15
SK287350B6 (sk) 2010-08-09
EG23993A (en) 2008-03-10
AU2002234240B2 (en) 2006-04-27
HRP20030566A2 (en) 2005-06-30
HUP0302764A3 (en) 2005-11-28
BR0206372A (pt) 2003-12-23
NZ527191A (en) 2004-04-30
WO2002057266A1 (fr) 2002-07-25
KR20040007438A (ko) 2004-01-24
US20040063931A1 (en) 2004-04-01
PT1353923E (pt) 2005-01-31
CA2433874C (fr) 2009-08-11
ATE278691T1 (de) 2004-10-15
HUP0302764A2 (hu) 2003-11-28
RS50494B (sr) 2010-03-02
YU55003A (sh) 2006-05-25
US7071330B2 (en) 2006-07-04
UA74870C2 (en) 2006-02-15
DE60201498D1 (de) 2004-11-11
ES2227423T3 (es) 2005-04-01
CN1249065C (zh) 2006-04-05
HRP20030566B1 (en) 2011-08-31
KR100827562B1 (ko) 2008-05-07
TWI318627B (en) 2009-12-21
EP1353923B1 (fr) 2004-10-06
EP1353923A1 (fr) 2003-10-22
PL362912A1 (en) 2004-11-02
SK8972003A3 (en) 2003-10-07
IL156507A (en) 2010-06-30
JP4098626B2 (ja) 2008-06-11
JP2004518672A (ja) 2004-06-24
AR035728A1 (es) 2004-07-07

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
DK1312406T3 (da) Fremgangsmåde til rensning af syntesegas
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DK1432319T3 (da) Fremgangsmåde til fremstilling af hundefoder
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1414492T3 (da) Fremgangsmåde til behandling af multipel myeloma
DK1373255T3 (da) Fremgangsmåde til fremstilling af imidazolforbindelser
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
IS7069A (is) Aðferð til að framleiða zaleplon
DK1294659T3 (da) Fremgangsmåde til isolering af katamin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
FI20012446A0 (fi) Menetelmä kartongin jälkikäsittelemiseksi
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
DK1400522T3 (da) Forbindelser til behandling af impotens
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DE60226093D1 (de) Urmedium-Reinigungsmethode
DK1472412T3 (da) Byggesæt af brosten
DK1670773T3 (da) Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter deraf
DK1373245T3 (da) Mellemprodukter til fremstilling af spinosyner
FI20011252A0 (fi) Rakennusmenetelmä
DK1229109T3 (da) Fremgangsmåde til fremstilling af glucose-1-phosphat
DK1455951T3 (da) Fremgangsmåde til fremstilling af belægninger